Patient Simulators Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Adult Patient Simulator, Infant Simulator, and Childbirth Simulator) and End User (Academic Institutes, Hospitals, and Military Organizations)

List of Tables

The patient simulators market is expected to grow from US$ 1,599.41 million in 2021 to US$ 4,284.03 million by 2028; it is estimated to register a CAGR of 15.2% from 2022 to 2028.

The market growth is attributed to the growing use of patient simulators for training purposes and the increasing demand for minimally invasive treatment methods. However, the high cost of patient simulators hampers the market growth.

A patient simulator is a manikin that mimics human anatomy or function (physiology), which can be used to train students and healthcare professionals. Clinical simulation allows practitioners of all levels and healthcare disciplines to practice and improve their clinical skills without any potential harm to patients. Patient simulators are most frequently used in academic institutions, academic medical centers, government research organizations, hospitals & clinics, and military training centers.

Growing Technological Advancements in Patient Simulators

There have been rapid advancements in healthcare technologies over the last few decades with the emergence of technologies such as virtual reality, augmented reality, artificial intelligence, robotics, 3D printing, and nanotechnology, and these will continue to shape the future of healthcare in the years to come. Advanced technology has made it possible that computer software can be integrated into manikins. The organs of one of these lifelike medical simulators, including their heart, blood vessels, lungs, and gastrointestinal tract, can also be made to respond to various human interventions during clinical simulation engagements. The computer software allows human patient simulators to replicate normal and abnormal bodily responses for educational and training purposes. Often these responses are initiated by several physical events, such as an asthma attack. Therapeutic interventions can also be replicated under certain circumstances, including representing a side effect of a medication.

More advanced simulators allow learners to use mixed reality viewer lenses to visualize the internal anatomy of a simulated patient. With these lenses, students can learn skills through observation and remote active participation. For instance, Gaumard's most advanced product combines mixed reality technology with a high-fidelity birthing simulator. With mixed reality goggles, a learner can visualize the baby and cardinal movements during decent while engaging in the hands-on exercise of delivering the baby. In the event of a complication, the learner can observe the mother's and baby's anatomy. Suppose the baby is not descending through the birth canal. In that case, learners can now manipulate the simulator in a specific way and receive visual feedback indicating that their legs have been moved to the proper position. With patient simulators, learners can practice these skills repeatedly to gain the muscle memory and critical thinking skills needed to react quickly during complicated procedures.

Thus, the growing technological advancement in simulation is expected to introduce new trends to the patient simulators market.

The patient simulators market in North America holds the largest share. The market growth in the region is attributed to the rising preference for patient simulators in nursing education and the availability of better healthcare facilities. In North America, the US is the largest market for patient simulators. In order to reduce the number of medical errors, the focus on providing medical education by using patient simulators has significantly increased in the US. Various manufacturers and training organizations have been offering training with the use of their patient simulators. For instance, The Johns Hopkins Medicine Simulation Center is a fully accredited state-of-the-art medical training facility that incorporates various types of simulation, including standardized patients and teaching associates, human patient simulation, virtual reality, task trainers, and computerized simulation. The primary goal of the center is to improve safety within patient care. These training centers not only help improve patient safety but also increase a clinician's comfort and response to an emergency situation.

Canada holds the second-largest share of the patient simulators market in North America. There have been various initiatives in Canada to promote the growth of the patient simulators market. Canada hosts a number of nonprofit institutes and organizations that work in the field of patient simulators. SIM-one-the Ontario Simulation Network-is a not-for-profit organization that connects the simulation community, as well as simulation facilities, resources, and services across Ontario. It also promotes and advances simulated learning in the health professions. SIM-one is fully supported by Ontario's Ministry of Health and Long-term Care.

The World Health Organization (WHO), National Library of Medicine, and whitepapers are among the secondary sources referred to while preparing the report on the patient simulators market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the patient simulators market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global patient simulators market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPMD00002250

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Patient Simulators Market - By Product
- 1.3.2 Global Patient Simulators Market - By End User
- 1.3.3 Global Patient Simulators Market - By Geography

2. Patient Simulators Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Patient Simulators Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East and Africa PEST Analysis
- 4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion

5. Patient Simulators Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Use of Patient Simulators for Training Purposes
- 5.1.2 Increase in Demand for Minimally Invasive Treatment Methods
5.2 Market Restraints
- 5.2.1 High Cost of Patient Simulators
5.3 Market Opportunities
- 5.3.1 Rising Awareness of Simulation Education
5.4 Future Trends
- 5.4.1 Growing Technological Advancements in Patient Simulators
5.5 Impact Analysis

6. Patient Simulators Market - Global Analysis

6.1 Global Patient Simulators Market Revenue Forecast and Analysis
6.2 Global Patient Simulators Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Global Patient Simulators Market - Revenue and Forecast to 2028 - by Product

7.1 Overview
7.2 Patient Simulators Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Adult Patient Simulators
- 7.3.1 Overview
- 7.3.2 Adult Patient Simulators: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Infant Simulators
- 7.4.1 Overview
- 7.4.2 Infant Simulators: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Childbirth Simulators
- 7.5.1 Overview
- 7.5.2 Childbirth Simulators: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Patient Simulators Market Analysis and Forecasts to 2028 - by End User

8.1 Overview
8.2 Global Patient Simulators Market, by End User 2021 & 2028 (%)
8.3 Academic Institutes
- 8.3.1 Overview
- 8.3.2 Academic Institutes: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Hospitals
- 8.4.1 Overview
- 8.4.2 Hospitals: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Military Organizations
- 8.5.1 Overview
- 8.5.2 Military Organizations: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)

9. Patient Simulators Market - Revenue and Forecast to 2028 - Geographic Analysis

9.1 North America: Patient Simulators Market
- 9.1.1 Overview
- 9.1.2 North America: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.3 North America: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
- 9.1.4 North America: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.1.4.1 US: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.4.1.1 Overview
    - 9.1.4.1.2 US: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.4.1.3 US: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.1.4.1.4 US: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.1.4.2 Canada Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.4.2.1 Overview
    - 9.1.4.2.2 Canada: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.4.2.3 Canada: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.1.4.2.4 Canada: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.1.4.3 Mexico: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.4.3.1 Overview
    - 9.1.4.3.2 Mexico: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.4.3.3 Mexico: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.1.4.3.4 Mexico: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
9.2 Europe: Patient Simulators Market
- 9.2.1 Overview
- 9.2.2 Europe: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.3 Europe: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
- 9.2.4 Europe: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
- 9.2.5 Europe: Patient Simulators Market, by Country, 2021 & 2028 (%)
  - 9.2.5.1 Germany: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.1.1 Overview
    - 9.2.5.1.2 Germany: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.1.3 Germany: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.2.5.1.4 Germany: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.2.5.2 UK: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.2.1 Overview
    - 9.2.5.2.2 UK: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.2.3 UK: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.2.5.2.4 UK: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.2.5.3 France: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.3.1 Overview
    - 9.2.5.3.2 France: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.3.3 France: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.2.5.3.4 France: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.2.5.4 Italy: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.4.1 Overview
    - 9.2.5.4.2 Italy: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.4.3 Italy: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.2.5.4.4 Italy: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.2.5.5 Spain: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.5.1 Overview
    - 9.2.5.5.2 Spain: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.5.3 Spain: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.2.5.5.4 Spain: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.2.5.6 Rest of Europe: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.6.1 Overview
    - 9.2.5.6.2 Rest of Europe: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.6.3 Rest of Europe: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.2.5.6.4 Rest of Europe: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
9.3 Asia Pacific: Patient Simulators Market
- 9.3.1 Overview
- 9.3.2 Asia Pacific: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.3 Asia Pacific: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
- 9.3.4 Asia Pacific: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
- 9.3.5 Asia Pacific: Patient Simulators Market, by Country, 2021 & 2028 (%)
  - 9.3.5.1 China: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.1.1 Overview
    - 9.3.5.1.2 China: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.1.3 China: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.3.5.1.4 China: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.3.5.2 Japan: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.2.1 Overview
    - 9.3.5.2.2 Japan: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.2.3 Japan: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.3.5.2.4 Japan: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.3.5.3 India: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.3.1 Overview
    - 9.3.5.3.2 India: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.3.3 India: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.3.5.3.4 India: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.3.5.4 Australia: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.4.1 Overview
    - 9.3.5.4.2 Australia: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.4.3 Australia: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.3.5.4.4 Australia: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.3.5.5 South Korea: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.5.1 Overview
    - 9.3.5.5.2 South Korea: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.5.3 South Korea: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.3.5.5.4 South Korea: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.3.5.6 Rest of Asia Pacific: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.6.1 Overview
    - 9.3.5.6.2 Rest of Asia Pacific: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.6.3 Rest of Asia Pacific: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.3.5.6.4 Rest of Asia Pacific: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
9.4 Middle East & Africa Patient Simulators Market
- 9.4.1 Overview
- 9.4.2 Middle East & Africa: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.3 Middle East & Africa: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
- 9.4.4 Middle East & Africa Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.4.4.1 South Africa: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.4.1.1 Overview
    - 9.4.4.1.2 South Africa: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.4.1.3 South Africa: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.4.4.1.4 South Africa Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.4.4.2 Saudi Arabia: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.4.2.1 Overview
    - 9.4.4.2.2 Saudi Arabia: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.4.2.3 Saudi Arabia: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.4.4.2.4 Saudi Arabia Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.4.4.3 UAE: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.4.3.1 Overview
    - 9.4.4.3.2 UAE: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.4.3.3 UAE: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.4.4.3.4 UAE Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.4.4.4 Rest of Middle East & Africa: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.4.4.1 Overview
    - 9.4.4.4.2 Rest of Middle East & Africa: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.4.4.3 Rest of Middle East & Africa: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.4.4.4.4 Rest of Middle East & Africa Patient Simulators Market, by End User, 2019-2028 (US$ Million)
9.5 South & Central America Patient Simulators Market
- 9.5.1 Overview
- 9.5.2 South & Central America: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.3 South & Central America: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
- 9.5.4 South & Central America: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
- 9.5.5 South & Central America: Patient Simulators Market, by Country, 2021 & 2028 (%)
  - 9.5.5.1 Brazil: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.5.5.1.1 Overview
    - 9.5.5.1.2 Brazil: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.5.5.1.3 Brazil: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.5.5.1.4 Brazil: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.5.5.2 Argentina: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.5.5.2.1 Overview
    - 9.5.5.2.2 Argentina: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.5.5.2.3 Argentina: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.5.5.2.4 Argentina: Patient Simulators Market, by End User, 2019-2028 (US$ Million)
  - 9.5.5.3 Rest of South & Central America: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.5.5.3.1 Overview
    - 9.5.5.3.2 Rest of South & Central America: Patient Simulators Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.5.5.3.3 Rest of South & Central America: Patient Simulators Market, by Product, 2019-2028 (US$ Million)
    - 9.5.5.3.4 Rest of South & Central America: Patient Simulators Market, by End User, 2019-2028 (US$ Million)

10. Impact Of COVID-19 Pandemic on Patient Simulators Market

10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South & Central America: Impact Assessment of COVID-19 Pandemic

11. Patient Simulators Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Patient Simulators Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 CAE Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Laerdal Medical AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Gaumard Scientific Co Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Kyoto Kagaku Co Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Surgical Science Sweden AB
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Simulab Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Simulaids Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Mentice AB
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Limbs & Things Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 VirtaMed AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms